CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2025-06-11 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +24,150 | 24,150 | ||
| 2024-06-14 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +23,000 | 23,000 | ||
| 2023-06-16 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +21,520 | 21,520 | ||
| 2022-06-17 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +21,520 | 21,520 | ||
| 2022-06-16 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +21,520 | 21,520 | ||
| 2021-06-09 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +21,520 | 21,520 |
Page 1 of 1 · 7 trades